TISSUE MICROARRAY COLLECTIONS

Colorectal cancer tissue microarrays & FFPE blocks

Explore colorectal cancer arrays with different tissue compositions and selected MSI, molecular, treatment or matched-plasma records. For FFPE blocks, share your tissue and study requirements with our team.

THE ARRAYS

Colorectal cancer arrays (28)

Collection types in this TMA catalog

Explore the tissue composition and sampling groups represented in these arrays.

Data labels reflect the catalog record. Review each product and datasheet for case-level coverage. Array counts do not indicate stock availability.

FFPE TISSUE BLOCKS

Colorectal cancer FFPE blocks for your study

Colorectal FFPE cohort profiles include MSS and dMMR/MSI-H disease, metastatic disease and selected KRAS, NRAS and BRAF groups.

FFPE blocks are requested by inquiry. Our team confirms tissue availability, donor matching and data coverage for your study.

COHORT HIGHLIGHTS

Representative FFPE cohort profiles

These examples are a starting point. Explore the corresponding FFPE indication for the full set of documented profiles and associated data.

Selected examples, not live inventory. Tissue and data availability are confirmed for your study.

SELECTING YOUR ARRAY

Selecting colorectal cancer tissue for your study

Compare the represented tissue and the available records before choosing an array. These examples describe individual catalog entries; data coverage is specific to each array.

Colorectal Cancer TMA & Matched Plasma

This colorectal cancer tissue microarray combines histopathology records with matched double-spun plasma, for selecting tissue with paired material.

Colorectal Cancer TMA: MSI & Follow-up

This colorectal cancer tissue microarray is listed with clinical follow-up and microsatellite instability (MSI) status. The array identifier distinguishes this collection from TA1114/02, which is listed with the same types of data.

Colorectal Cancer TMA: Bevacizumab Follow-up

This primary colorectal cancer tissue microarray is listed with bevacizumab treatment and follow-up data in metastatic and adjuvant settings, together with KRAS mutation status. Check the case records for the treatment setting relevant to your study.